Cannabis-based Products for Medicinal Use

Applicable to: This policy applies to any health practitioner or other staff member employed in the WA health system required to obtain, possess, store, prescribe, administer, dispense or supply a cannabis-based product for medicinal purposes as a Scheduled medicine.

MP 0039/16 will be superseded by MP 0139/20 Medicines Handling Policy on 01 December 2020. MP 0039/16 will remain in effect until this time. For further information, please contact the Medicines and Poisons Regulation Branch

Description: The Cannabis-based Products for Medicinal Use Policy provides regulatory, research and governance guidance to health services and health practitioners in relation to medicinal cannabis.

Date of effect: 01 November 2016 to 01 November 2018

Policy Framework